Stocklytics Platform
Asset logo for symbol ZBH
Zimmer Biomet Holdings
ZBH62
$107.30arrow_drop_up0.45%$0.48
S&P500
Asset logo for symbol ZBH
ZBH62

$107.30

arrow_drop_up0.45%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Zimmer Biomet Holdings (ZBH) Stocklytics Forecast

Zimmer Biomet Holdings Inc. (ZBH) is a global leader in musculoskeletal healthcare, providing medical devices and solutions for patients around the world. With a strong track record of innovation and a commitment to improving patient outcomes, Zimmer Biomet has established itself as a trusted brand in the healthcare industry. Investors looking for a stock with long-term growth potential may want to consider Zimmer Biomet Holdings Inc.
So, what does the future hold for Zimmer Biomet Holdings Inc? There are several factors that could impact the company's stock price in the coming years. One key factor to consider is the aging population. As the baby boomer generation continues to age, there is expected to be a growing demand for musculoskeletal healthcare products and services. Zimmer Biomet is well-positioned to capitalize on this trend, as the company specializes in orthopedic implants and other devices that help improve mobility and quality of life for older adults.
add Zimmer Biomet Holdings  to watchlist

Keep an eye on Zimmer Biomet Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Zimmer Biomet Holdings (ZBH) stock?

Analysts have set a target price of $135.11 for Zimmer Biomet Holdings (ZBH), based on forecasts from 19 analysts. The predicted price range extends from a high of $172 to a low of $115. This represents a potential increase of up to 60.3% and a decrease of 7.18% from the current price of $107.3. These forecasts are as of 2023 May 18.
help

What are the analyst ratings for Zimmer Biomet Holdings (ZBH) stock?

The analyst ratings for Zimmer Biomet Holdings (ZBH) are distributed as follows: 10 analysts recommend buying, 18 have a neutral stance, and 2 suggest selling. The prevailing sentiment among the total of 30 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Zimmer Biomet Holdings .
help

What is the AI price prediction for Zimmer Biomet Holdings (ZBH) stock?

At present, there is no AI or machine-learning-based price prediction available for Zimmer Biomet Holdings (ZBH) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level